Mapletree Logistics Trust to sell Tuas warehouse for S$10.5 million

Mapletree Logistics Trust to sell Tuas warehouse for S$10.5 million

MAPLETREE Logistics Trust is planning to sell a warehouse located in Tuas South Avenue for S$10.5 million, as part of the real estate investment trust’s (Reit) efforts to refresh its portfolio. The Reit’s trustee, HSBC Institutional Trust Services, has entered into a purchase agreement with an unrelated third-party buyer for the proposed sale of the…

Read More

Tata Motors Q4 profit jumps over three-fold

Tata Motors Q4 profit jumps over three-fold

Indian carmaker Tata Motors reported a three-fold jump in fourth-quarter profit on Friday (May 10), helped by a tax credit surge and strong sales at its luxury unit Jaguar Land Rover (JLR). The company said it expects JLR’s earnings before interest and taxes (EBIT) margins in fiscal 2025 would be similar to the 8.5 per…

Read More

Keppel sells stake in Dyna-Mac for S$100 million

Keppel sells stake in Dyna-Mac for S$100 million

KEPPEL’s subsidiary has sold its entire stake in oil and gas company Dyna-Mac : NO4 0% to Hanwha Group for S$100 million, as the conglomerate continues its shift towards becoming an asset manager. Keppel’s : BN4 0% entire stake in Dyna-Mac – held by subsidiary KepInvest Holdings – accounted for 23.9 per cent of the…

Read More

STI climbs 0.8% on Friday, tracking regional rally

STI climbs 0.8% on Friday, tracking regional rally

SINGAPORE stocks closed higher on Friday (May 10), tracking a broader regional rally. The benchmark Straits Times Index (STI) climbed 0.8 per cent or 24.75 points to close at 3,290.70. The market barometer was little changed over the trading week. Just two STI counters ended in the red on Friday, with Seatrium : 5E2 0%falling…

Read More

New weight-loss, diabetes drugs reach one in eight Americans

New weight-loss, diabetes drugs reach one in eight Americans

ONE in eight US adults has tried medications from the fast-growing class of new diabetes and obesity drugs that includes Ozempic and Zepbound, underscoring how quickly the treatments have gained popularity. Of those who’ve tried the drugs, about half are currently still taking them, according to a poll from health research organisation KFF released on…

Read More

Sanofi inks US$1.2 billion vaccine licensing deal with Novavax

Sanofi inks US$1.2 billion vaccine licensing deal with Novavax

Sanofi and Novavax signed a licensing agreement that includes commercialising a combined Covid-19 and flu shot.  Novavax will receive US$500 million in upfront payments as well as US$700 million in development, regulatory and launch milestones, according to a statement on Friday (May 10). Sanofi is also taking a minority equity stake of about 5 per…

Read More